Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3717893016 | Abacavir and dolutegravir and lamivudine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3717894010 | Product containing only abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Abacavir and dolutegravir and lamivudine only product in oral dose form | Has active ingredient | Dolutegravir | true | Inferred relationship | Some | 3 | |
Abacavir and dolutegravir and lamivudine only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Abacavir and dolutegravir and lamivudine only product in oral dose form | Has active ingredient | Abacavir (substance) | true | Inferred relationship | Some | 2 | |
Abacavir and dolutegravir and lamivudine only product in oral dose form | Is a | Product containing abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Abacavir and dolutegravir and lamivudine only product in oral dose form | Has active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 1 | |
Abacavir and dolutegravir and lamivudine only product in oral dose form | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Abacavir and dolutegravir and lamivudine only product in oral dose form | Is a | Abacavir and dolutegravir and lamivudine only product | true | Inferred relationship | Some | ||
Abacavir and dolutegravir and lamivudine only product in oral dose form | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Abacavir and dolutegravir and lamivudine only product in oral dose form | Inferred relationship | Some |
Reference Sets